Primary biliary cirrhosis: Historical perspective

Clinics in Liver Disease

Volumn 7, Issue 4, 2003, Pages 735-740

  Heathcote, E Jenny ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; CHOLERETIC AGENT; IMMUNOSUPPRESSIVE AGENT; MITOCHONDRION ANTIBODY;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; DISEASE COURSE; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; LIVER DISEASE; LIVER HISTOLOGY; PRIMARY BILIARY CIRRHOSIS; REVIEW;

EID: 0141960204     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(03)00098-9     Document Type: Review

References (21)

1. Addison T, Gull W. On a certain affection of the skin vitiligoidea-α plana, β tuberosa. Guy's Hosp Rep 1851;7:265-76.
2. Hanot V. La cirrhosis hypertrophique avec ictere chronique. Paris: Rueff et Cie; 1892.
3. Ahrens Jr EH, Payne MA, Kunkel HG, Eisenmenger WJ, Blondheim SH. Primary biliary cirrhosis. Medicine 1950;29:299-364.
4. Sherlock S. Primary Biliary Cirrhosis (Chronic intrahepatic obstructive jaundice). Gastroenterology 1959;37:574-86.
5. Walker JG, Doniach D, Roitt IM, et al. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1965;1:827-31.
6. Fussey S, Guest J, James O, et al. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988;85:8654-8.
7. Van de Water J, Gershwin ME, Leung P, Ansari A, Coppel RL. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 1988;167:1791-9.
8. Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis: chronic non-suppurative destructive cholangitis. Am J Pathol 1965;46:387-407.
9. Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med 1967;60:1257-60.
10. Mitchison HC, Bassendine MF, Hendrick A, Bennett MK, Bird G, Watson AJ, et al. Positive antimitochondrial antibody but normal alkaline phosphatase: Is this primary biliary cirrhosis? Hepatology 1986;6(6):1279-84.
11. James OFW, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV. Primary Biliary Cirrhosis once rare, now common in the United Kingdom? Hepatology 1999;30(2):390-4.
12. Prince M, Chetwynd A, Newman W, Metcalf JV, James OFW. Survival and symptom progression in a geographically based cohort of patients with Primary Biliary Cirrhosis: follow-up for up to 28 years. Gastroenterology 2002;123:1044-51.
13. Feizi T, Naccarato R, Sherlock S, Doniach D. Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol 1972;10:609-22.
14. Jones DEJ, Watt FE, Metcalf JV, Bassendine MF, James OFW. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999;30:402-7.
15. Douglas JG, Finlayson ND. Are increased individual susceptibility and environmental factors both necessary for the development of primary biliary cirrhosis? BMJ 1979;2:419-20.
16. Triger D. Primary Biliary Cirrhosis: an epidemiological study. BMJ 1980;281:772-5.
17. Tsuji K, Watanabe Y, Van de Water J, Nakanishi T, Kajiyama G, Parikh-Patel A, et al. Familial Primary Biliary Cirrhosis in Hiroshima. J Autoimmun 1999;13:171-8.
18. Prince MI, Chetwynd A, Diggle P, Jarner M, Metcalf JV, James OFW. The geographical distribution of Primary Biliary Cirrhosis in a well-defined cohort. Hepatology 2001;34(6):1083-8.
19. Howel D, Fischbacher CM, Bhopal RS, Gray J, Metcalf JV, James OFW. An exploratory population-based case-control study of Primary Biliary Cirrhosis. Hepatology 2000;31(5):1055-60.
20. Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 2001;33(1):16-21.
21. Long SA, Quan C, Van de Water J, Nantz MH, Kurth MJ, Barsky D, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001;167:2956-63.